Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

New endpoints in early clinical trials

Incorporating ctDNA into RECIST v1.1: Steps ahead

Date

13 Sep 2024

Session

New endpoints in early clinical trials

Topics

Molecular Oncology;  Genetic and Genomic Testing;  Response Evaluation (RECIST Criteria)

Tumour Site

Presenters

Elena Garralda

Authors

E. Garralda

Author affiliations

  • Early Drug Development Dept., Vall d'Hebron University Hospital, 8035 - Barcelona/ES

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: New endpoints in early clinical trials

Resources:

Webcast

Conclusions and perspectives

Presenter: Neeltje Steeghs

Session: New endpoints in early clinical trials

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.